Cleerly
Provides AI-driven solutions to analyze and prevent heart disease.
Company facts
- Founded
- 2017
- Employees
- 314
- Headquarters
- United States
- CEO
- James K. Min, MD
- Type
- Private
- Funding
- Series C · $106M · 2024
About
Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.